- Home
- KOPN vs ZBIO Comparison
KOPN vs ZBIO Comparison
Compare KOPN & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- ZBIO
- Stock Information
- Founded
- KOPN 1984
- ZBIO 2019
- Country
- KOPN United States
- ZBIO United States
- Employees
- KOPN N/A
- ZBIO N/A
- Industry
- KOPN Semiconductors
- ZBIO
- Sector
- KOPN Technology
- ZBIO
- Exchange
- KOPN Nasdaq
- ZBIO NYSE
- Market Cap
- KOPN 255.1M
- ZBIO 389.2M
- IPO Year
- KOPN 1992
- ZBIO 2024
- Fundamental
- Price
- KOPN $1.69
- ZBIO $12.90
- Analyst Decision
- KOPN Strong Buy
- ZBIO Strong Buy
- Analyst Count
- KOPN 3
- ZBIO 7
- Target Price
- KOPN $2.58
- ZBIO $32.29
- AVG Volume (30 Days)
- KOPN 3.0M
- ZBIO 180.1K
- Earning Date
- KOPN 08-07-2025
- ZBIO 08-16-2025
- Dividend Yield
- KOPN N/A
- ZBIO N/A
- EPS Growth
- KOPN N/A
- ZBIO N/A
- EPS
- KOPN N/A
- ZBIO N/A
- Revenue
- KOPN $50,841,018.00
- ZBIO $15,000,000.00
- Revenue This Year
- KOPN $8.02
- ZBIO $165.20
- Revenue Next Year
- KOPN $20.99
- ZBIO $63.75
- P/E Ratio
- KOPN N/A
- ZBIO N/A
- Revenue Growth
- KOPN 28.16
- ZBIO N/A
- 52 Week Low
- KOPN $0.56
- ZBIO $5.83
- 52 Week High
- KOPN $2.17
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- KOPN 61.67
- ZBIO N/A
- Support Level
- KOPN $1.51
- ZBIO N/A
- Resistance Level
- KOPN $1.76
- ZBIO N/A
- Average True Range (ATR)
- KOPN 0.09
- ZBIO 0.00
- MACD
- KOPN 0.00
- ZBIO 0.00
- Stochastic Oscillator
- KOPN 78.13
- ZBIO 0.00
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.